{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:38:44Z","timestamp":1792147124192,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,8,12]],"date-time":"2012-08-12T00:00:00Z","timestamp":1344729600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s12185-012-1156-0","type":"journal-article","created":{"date-parts":[[2012,8,11]],"date-time":"2012-08-11T09:06:23Z","timestamp":1344675983000},"page":"443-449","source":"Crossref","is-referenced-by-count":18,"title":["Clonal expansion of Epstein\u2013Barr virus (EBV)-infected \u03b3\u03b4 T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions"],"prefix":"10.1007","volume":"96","author":[{"given":"Taizo","family":"Wada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Toga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonari","family":"Shigemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunaga","family":"Agematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Yachie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,12]]},"reference":[{"key":"1156_CR1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","volume":"25","author":"AD Hislop","year":"2007","unstructured":"Hislop AD, Taylor GS, Sauce D, Rickinson AB. Cellular responses to viral infection in humans: lessons from Epstein\u2013Barr virus. Annu Rev Immunol. 2007;25:587\u2013617.","journal-title":"Annu Rev Immunol"},{"key":"1156_CR2","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","volume":"20","author":"JI Cohen","year":"2009","unstructured":"Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES. Epstein\u2013Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8\u20139 September 2008. Ann Oncol. 2009;20:1472\u201382.","journal-title":"Ann Oncol"},{"key":"1156_CR3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.20398","volume":"80","author":"M Okano","year":"2005","unstructured":"Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, Morio T, Mori M, Yokota S, Imashuku S. Proposed guidelines for diagnosing chronic active Epstein\u2013Barr virus infection. Am J Hematol. 2005;80:64\u20139.","journal-title":"Am J Hematol"},{"key":"1156_CR4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/427239","volume":"191","author":"H Kimura","year":"2005","unstructured":"Kimura H, Hoshino Y, Hara S, Sugaya N, Kawada J, Shibata Y, Kojima S, Nagasaka T, Kuzushima K, Morishima T. Differences between T cell-type and natural killer cell-type chronic active Epstein\u2013Barr virus infection. J Infect Dis. 2005;191:531\u20139.","journal-title":"J Infect Dis"},{"key":"1156_CR5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0190-9622(00)90127-0","volume":"42","author":"G Gupta","year":"2000","unstructured":"Gupta G, Man I, Kemmett D. Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol. 2000;42:208\u201313.","journal-title":"J Am Acad Dermatol"},{"key":"1156_CR6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2133.2002.04862.x","volume":"147","author":"HH Chen","year":"2002","unstructured":"Chen HH, Hsiao CH, Chiu HC. Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma. Br J Dermatol. 2002;147:587\u201391.","journal-title":"Br J Dermatol"},{"key":"1156_CR7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1365-2133.1999.02777.x","volume":"140","author":"K Iwatsuki","year":"1999","unstructured":"Iwatsuki K, Xu Z, Takata M, Iguchi M, Ohtsuka M, Akiba H, Mitsuhashi Y, Takenoshita H, Sugiuchi R, Tagami H, Kaneko F. The association of latent Epstein\u2013Barr virus infection with hydroa vacciniforme. Br J Dermatol. 1999;140:715\u201321.","journal-title":"Br J Dermatol"},{"key":"1156_CR8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2133.2004.06038.x","volume":"151","author":"KH Cho","year":"2004","unstructured":"Cho KH, Lee SH, Kim CW, Jeon YK, Kwon IH, Cho YJ, Lee SK, Suh DH, Chung JH, Yoon TY, Lee SJ. Epstein\u2013Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases. Br J Dermatol. 2004;151:372\u201380.","journal-title":"Br J Dermatol"},{"key":"1156_CR9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archderm.142.5.587","volume":"142","author":"K Iwatsuki","year":"2006","unstructured":"Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M, Xu ZG, Suzuki D, Tsuji K. Pathogenic link between hydroa vacciniforme and Epstein\u2013Barr virus-associated hematologic disorders. Arch Dermatol. 2006;142:587\u201395.","journal-title":"Arch Dermatol"},{"key":"1156_CR10","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/605610","volume":"200","author":"H Kimura","year":"2009","unstructured":"Kimura H, Miyake K, Yamauchi Y, Nishiyama K, Iwata S, Iwatsuki K, Gotoh K, Kojima S, Ito Y, Nishiyama Y. Identification of Epstein\u2013Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases. J Infect Dis. 2009;200:1078\u201387.","journal-title":"J Infect Dis"},{"key":"1156_CR11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, Naoe T, Esaki S, Kikuta A, Sawada A, Kawa K, Ohshima K, Nakamura S. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119:673\u201386.","journal-title":"Blood"},{"key":"1156_CR12","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/jid.2011.461","volume":"132","author":"Y Hirai","year":"2012","unstructured":"Hirai Y, Yamamoto T, Kimura H, Ito Y, Tsuji K, Miyake T, Morizane S, Suzuki D, Fujii K, Iwatsuki K. Hydroa vacciniforme is associated with increased numbers of Epstein\u2013Barr virus-infected \u03b3\u03b4 T Cells. J Invest Dermatol. 2012;132:1401\u20138.","journal-title":"J Invest Dermatol"},{"key":"1156_CR13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2133.2011.10512.x","volume":"166","author":"C Tanaka","year":"2012","unstructured":"Tanaka C, Hasegawa M, Fujimoto M, Iwatsuki K, Yamamoto T, Yamada K, Kawa K, Saikawa Y, Toga A, Mase S, Wada T, Takehara K, Yachie A. Phenotypic analysis in a case of hydroa vacciniforme-like eruptions associated with chronic active Epstein\u2013Barr virus disease of \u03b3\u03b4 T cells. Br J Dermatol. 2012;166:216\u20138.","journal-title":"Br J Dermatol"},{"key":"1156_CR14","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1086\/652752","volume":"201","author":"A Toga","year":"2010","unstructured":"Toga A, Wada T, Sakakibara Y, Mase S, Araki R, Tone Y, Toma T, Kurokawa T, Yanagisawa R, Tamura K, Nishida N, Taneichi H, Kanegane H, Yachie A. Clinical significance of cloned expansion and CD5 down-regulation in Epstein\u2013Barr virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis. J Infect Dis. 2010;201:1923\u201332.","journal-title":"J Infect Dis"},{"key":"1156_CR15","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1172\/JCI25178","volume":"115","author":"JP Villartay de","year":"2005","unstructured":"de Villartay JP, Lim A, Al-Mousa H, Dupont S, Dechanet-Merville J, Coumau-Gatbois E, Gougeon ML, Lemainque A, Eidenschenk C, Jouanguy E, Abel L, Casanova JL, Fischer A, Le Deist F. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest. 2005;115:3291\u20139.","journal-title":"J Clin Invest"},{"key":"1156_CR16","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1172\/JCI25221","volume":"115","author":"S Ehl","year":"2005","unstructured":"Ehl S, Schwarz K, Enders A, Duffner U, Pannicke U, Kuhr J, Mascart F, Schmitt-Graeff A, Niemeyer C, Fisch P. A variant of SCID with specific immune responses and predominance of \u03b3\u03b4 T cells. J Clin Invest. 2005;115:3140\u20138.","journal-title":"J Clin Invest"},{"key":"1156_CR17","doi-asserted-by":"crossref","first-page":"8697","DOI":"10.1073\/pnas.151260498","volume":"98","author":"T Wada","year":"2001","unstructured":"Wada T, Schurman SH, Otsu M, Garabedian EK, Ochs HD, Nelson DL, Candotti F. Somatic mosaicism in Wiskott\u2013Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Natl Acad Sci USA. 2001;98:8697\u2013702.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1156_CR18","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ Dongen van","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257\u2013317.","journal-title":"Leukemia"},{"key":"1156_CR19","unstructured":"Quintanilla-Martinez L KH, Jaffe ES. EBV-positive T-cell lymphoproliferative disorders of childhood. Geneva, Switzerland: World Health Organization, 2008."},{"key":"1156_CR20","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1172\/JCI5409","volume":"103","author":"J Dechanet","year":"1999","unstructured":"Dechanet J, Merville P, Lim A, Retiere C, Pitard V, Lafarge X, Michelson S, Meric C, Hallet MM, Kourilsky P, Potaux L, Bonneville M, Moreau JF. Implication of \u03b3\u03b4 T cells in the human immune response to cytomegalovirus. J Clin Invest. 1999;103:1437\u201349.","journal-title":"J Clin Invest"},{"key":"1156_CR21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-065X.2006.00477.x","volume":"215","author":"RL O\u2019Brien","year":"2007","unstructured":"O\u2019Brien RL, Roark CL, Jin N, Aydintug MK, French JD, Chain JL, Wands JM, Johnston M, Born WK. \u03b3\u03b4 T-cell receptors: functional correlations. Immunol Rev. 2007;215:77\u201388.","journal-title":"Immunol Rev"},{"key":"1156_CR22","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.4049\/jimmunol.153.9.3979","volume":"153","author":"CT Morita","year":"1994","unstructured":"Morita CT, Parker CM, Brenner MB, Band H. TCR usage and functional capabilities of human gamma delta T cells at birth. J Immunol. 1994;153:3979\u201388.","journal-title":"J Immunol"},{"key":"1156_CR23","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1084\/jem.171.5.1597","volume":"171","author":"CM Parker","year":"1990","unstructured":"Parker CM, Groh V, Band H, Porcelli SA, Morita C, Fabbi M, Glass D, Strominger JL, Brenner MB. Evidence for extrathymic changes in the T cell receptor gamma\/delta repertoire. J Exp Med. 1990;171:1597\u2013612.","journal-title":"J Exp Med"},{"key":"1156_CR24","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0002-9440(10)64297-6","volume":"162","author":"MK Oyoshi","year":"2003","unstructured":"Oyoshi MK, Nagata H, Kimura N, Zhang Y, Demachi A, Hara T, Kanegane H, Matsuo Y, Yamaguchi T, Morio T, Hirano A, Shimizu N, Yamamoto K. Preferential expansion of V\u03b39-J\u03b3P\/V\u03b42-J\u03b43 \u03b3\u03b4 T cells in nasal T-cell lymphoma and chronic active Epstein\u2013Barr virus infection. Am J Pathol. 2003;162:1629\u201338.","journal-title":"Am J Pathol"},{"key":"1156_CR25","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.coi.2006.06.001","volume":"18","author":"HK Komori","year":"2006","unstructured":"Komori HK, Meehan TF, Havran WL. Epithelial and mucosal gamma delta T cells. Curr Opin Immunol. 2006;18:534\u20138.","journal-title":"Curr Opin Immunol"},{"key":"1156_CR26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2133.2010.09826.x","volume":"163","author":"L Verneuil","year":"2010","unstructured":"Verneuil L, Gouarin S, Comoz F, Agbalika F, Creveuil C, Varna M, Vabret A, Janin A, Leroy D. Epstein\u2013Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up. Br J Dermatol. 2010;163:174\u201382.","journal-title":"Br J Dermatol"},{"key":"1156_CR27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2249.2004.02458.x","volume":"136","author":"T Yoshimasu","year":"2004","unstructured":"Yoshimasu T, Nishide T, Seo N, Hiroi A, Ohtani T, Uede K, Furukawa F. Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus. Clin Exp Immunol. 2004;136:245\u201354.","journal-title":"Clin Exp Immunol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1156-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-012-1156-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1156-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T08:31:44Z","timestamp":1687681904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-012-1156-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,12]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["1156"],"URL":"https:\/\/doi.org\/10.1007\/s12185-012-1156-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,12]]}}}